(Q72400009)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

5-Fluorouracil causes alterations in the pharmacokinetic profile of tauromustine in NMRI mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

1 reference

S R Hill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M C Bibby

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

57-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study

26 October 2019

cites work

1 reference

12 December 2020

Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse model

1 reference

12 December 2020

Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma

1 reference

12 December 2020

Current treatment approaches in colorectal cancer

1 reference

12 December 2020

120-hour 5-fluorouracil (5-FU) continuous infusion (CI) plus BCNU in advanced colorectal cancer

1 reference

12 December 2020

Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice

1 reference

12 December 2020

Determination of tauromustine and its demethylated metabolites in plasma and urine

1 reference

12 December 2020

5-Fluorouracil plus tauromustine in advanced colorectal cancer: unexpected negative results

1 reference

12 December 2020

Combination chemotherapy with tauromustine (TCNU), 5-fluorouracil and leucovorin in advanced colorectal carcinoma: a dose-finding study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174203%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference